Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Gen Z’s expensive drug habit: Younger patients want brand-name meds that are 79% more expensive

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research suggests.

Fortune

Igloo Recalls A Million Coolers Over Fingertip Amputations

The Consumer Product Safety Commission alerted consumers about the recall on Thursday.

International Business Times

Parents can soon use QR codes to reveal heavy metal content in baby food

Parents across the U.S. should soon be able to determine how much lead, arsenic, cadmium and mercury are in the food they feed their babies, thanks to a California law, the first of its kind, that took effect this year.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

I Left Florida To Try Lab-Grown Meat

When Florida Gov. Ron DeSantis banned cultivated meat, Reason's Zach Weissmueller visited California labs to try cultivated chicken and salmon and explore the future of this industry.

Reason

Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial

Eli Lilly is still seeing rapid sales growth for its diabetes and weight loss drugs. However, one drug waiting in the wings hopes to be its next blockbuster.

MarketBeat

Massive pastry recall hits Dunkin'

Affected items may include cinnamon sticks, filled and flavored donuts, French crullers and fritters

Salon

Wall Street Predicts This Dividend Stock to Soar 31%: Should You Buy The Dip Now?

Amgen stock is an attractive buy on the dip for passive income-focused investors.

Barchart

Read news from The Economist, FT, and more,
with one subscription

GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.

MarketBeat

House cats with bird flu could pose risk

Pet owners probably shouldn't be afraid their cats will give them bird flu but taking precautions is good for pets

Salon

Musk Seemingly Calls for Term Limits as Federal Judge Orders HHS, CDC and FDA to Restore Deleted Webpages: 'Truly Absurd'

Elon Musk demands the removal of a federal judge after a ruling forcing HHS, CDC, and FDA to restore deleted webpages, calling it "truly absurd."

Latin Times

Federal Judge Orders Restoration Of Health Webpages

Federal judge issues restraining order to restore health-related webpages removed due to executive order, impacting patient care and research.

Top News

Judge tells agencies to restore webpages and data removed after Trump's executive order

A federal judge has told government agencies to restore public access to health-related webpages and datasets they removed to comply with an executive order by President Donald Trump

The Independent UK

2 ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street

The recent advancements in their pipelines imply high growth potential in the coming years.

Barchart

Ozempic, Wegovy maker claps back at Hims & Hers Super Bowl ad: ‘Check before you inject’

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

The Independent UK

Tuna cans sold at Trader Joe’s, Walmart and Costco recalled due to contamination risk

The recall came after a manufacturing defect in the tuna cans’ ‘easy open’ lids was discovered

The Independent UK

McDonald's improving global sales help to offset US weakness in fourth quarter

Improving international sales helped McDonald’s overcome some weakness at home in the fourth quarter

Salon

Is a new painkiller too good to be true?

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Two million cases of donuts recalled over contamination risk

The recalled donuts were sold in the U.S. and Canada

The Times of India

Are smartphone diabetes devices putting lives in danger? US FDA sounds alarm

The U.S. Food and Drug Administration (US FDA) has said patients using diabetes devices that rely on smartphones, sometimes fail to receive alerts critical for their health.

International Business Times

FDA Warns Of Missed Alerts On Phone-Connected Diabetes Devices, Leading To 'Serious Harm'

The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous glucose monitors.

Salon

A gentler drug overdose reversal

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose

Top News

FDA Warns Of Health Risks From Diabetes App Notifications

FDA warns of health risks from missed alerts on diabetes management apps, emphasizing the need for proper device functioning to ensure patient safety.

The Times of India

US FDA recalls broccoli from stores due to contamination and risk of death: Here's all about it

The U.S. Food and Drug Administration has elevated the risk warning for broccoli sold at Walmart. The warning, which was originally issued in December, has been increased to the highest recall category of the FDA, reports have said.

The Independent UK

Patients using diabetes apps can miss critical alerts. Here's how to make sure you're getting them

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes

1 … 53 54 55 56

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.